PARSEC FINANCIAL MANAGEMENT, INC. – Regeneron Pharmaceuticals, Inc. Transaction History
PARSEC FINANCIAL MANAGEMENT, INC. portfolio value:
$6.53M
portfolio value
PARSEC FINANCIAL MANAGEMENT, INC. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +4.20% | 383 shares | 1.15M | $688.87 | 9.49K |
Q2 2022 | share | Increase | +4.29% | 375 shares | -715K | $591.13 | 9.10K |
Q1 2022 | share | Increase | +8.12% | 656 shares | 999K | $698.42 | 8.73K |
Q4 2021 | share | Increase | +3.25% | 254 shares | 279K | $642.51 | 8.07K |
Q3 2021 | share | Increase | +14.29% | 978 shares | 998K | $605.18 | 7.82K |
Q2 2021 | share | Increase | +8.25% | 522 shares | 832K | $558.54 | 6.84K |
Q1 2021 | share | Increase | +14.36% | 794 shares | 320K | $473.14 | 6.32K |
Q4 2020 | share | Increase | +0.53% | 29 shares | -407K | $483.11 | 5.53K |
Q3 2020 | share | Decrease | -4.73% | -273 shares | -522K | $559.78 | 5.50K |
Q2 2020 | share | Decrease | -8.58% | -542 shares | 517K | $623.65 | 5.77K |
Q1 2020 | share | Decrease | -16.13% | -1.21K shares | 256K | $488.29 | 6.31K |
Q4 2019 | share | Decrease | -32.01% | -3.54K shares | -244K | $375.48 | 7.53K |
Q3 2019 | share | Decrease | -28.97% | -4.51K shares | -1.80M | $277.4 | 11.07K |
Q2 2019 | share | Increase | +89.73% | 7.37K shares | 1.50M | $313 | 15.59K |
Q1 2019 | share | Increase | +244.04% | 5.83K shares | 2.48M | $410.62 | 8.21K |
Q4 2018 | share | Increase | 0.00% | 2.38K shares | 892K | $373.5 | 2.38K |